Kathryn DiMarco
Net worth: 516 792 $ as of 2026-05-30
Net worth: 516 792 $ as of 2026-05-30
Ms. Kathryn DiMarco is a Senior Vice President-Finance & Controller at Organon & Co. Ms. DiMarco was previously employed as a Controller by Allergan Ltd. (Ireland) and an International Controller by Merck Sharp & Dohme Corp.
She received her undergraduate degree from Lehigh University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ORGANON & CO. 0.01% | 2025-03-30 | 38,740 ( 0.01% ) | 516 792 $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
| ORGANON & CO. | Comptroller/Controller/Auditor | 2025-04-30 |
| ALLERGAN PLC | Comptroller/Controller/Auditor | 2019-12-31 |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Comptroller/Controller/Auditor | 2014-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Organon & Co.
Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions